NCT06731478 2026-03-16
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
Daiichi Sankyo
Phase 3 Recruiting
Daiichi Sankyo
Amgen
Fudan University
Ruijin Hospital
Shanghai Zhongshan Hospital
Huazhong University of Science and Technology
Sun Yat-sen University
Sun Yat-sen University